drugset / Trial / NCT00685802
Fasted Bioavailability Study of Cilostazol Tablets, 50mg
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to evaluate and compare the relative bioavailability of a test formulation of cilostazol tablets to an equivalent dose of Pletal® (cilostazol) tablets after a single oral dose administered under fasting conditions.
Timeline
- Start
- 2004-06
- Primary completion
- 2004-07
- Completion
- 2004-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cilostazol | Small molecule | 100 mg | Oral |
Indications
No indication recorded.